The supercomputer, named Cambridge-1, will be part of NVIDIA’s AI Centre of Excellence in Cambridge and will feature more than 400 petaflops (one quadrillion floating point operations per second (FLOPS)), making it the 29th most powerful computer in the world as well as the 3rd most energy-efficient.
Cambridge-1 will harness the power of artificial intelligence (AI) to transform healthcare research and discovery through:
- Joint industry research to solve large-scale healthcare and data-science problems
- University-granted compute time will be donated as a resource to specific university projects
- Supporting startups by providing early access to AI tools
- Educating future AI practitioners by providing hands-on experience to nurture the next generation of world-class researchers
GSK, AstraZeneca, Guy’s and St Thomas’ NHS Foundation Trust, King’s College London and Oxford Nanopore Technologies have already signed up to be the first users of Cambridge-1, which is expected to come online by the end of 2020.
Jensen Huang, NVIDIA founder and CEO, said:
“Tackling the world’s most pressing challenges in healthcare requires massively powerful computing resources to harness the capabilities of AI. The Cambridge-1 supercomputer will serve as a hub of innovation for the UK, and further the groundbreaking work being done by the nation’s researchers in critical healthcare and drug discovery.”
Matt Hancock, Secretary of State for Health and Social Care, said:
“Today’s announcement from NVIDIA is an exciting moment for the UK’s world-leading healthcare industry and a tremendous vote of confidence in the UK as an international centre for research, AI and innovation. Accelerating drug discovery has never been so important and it is investments like this that can make a real difference in our fight against countless diseases.”
For full specifications of Cambridge-1 and further information, please see NVIDIA’s press release.